Phase II Study of ASP0456 - A Double-blind, Placebo-controlled, Parallel-group, Comparative Study in Patients With Constipation-predominant Irritable Bowel Syndrome
Phase of Trial: Phase II
Latest Information Update: 01 May 2018
Price : $35 *
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 19 May 2016 According to an Ironwood Pharmaceuticals media release, the company will present clinical data from this study at the Digestive Disease Week (DDW) 2016.
- 25 Nov 2014 New source identified and integrated (ClinicalTrials.gov; NCT01714843).
- 01 Dec 2013 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.